FDA
approval
· 2024-01-16
FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for butorphanol tartrate by Hikma Pharmaceuticals USA Inc. (ANDA 078400). This action confirms continued regulatory appr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)